RESEARCH
AI platforms predict molecular alterations from routine pathology slidesA review of 30 studies found that artificial intelligence platforms can detect MSI, MMR status, and mutations in BRAF, KRAS, NRAS, and TP53 from hematoxylin and eosin-stained slides, potentially reducing cost and turnaround time. (Int J Mol Sci)